Theophylline
Product Images NDC 42858-701

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 42858-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Theophylline 01

Theophylline 01
Chemical structure diagram of the active ingredient theophylline anhydrous, showing its molecular arrangement with labeled atoms and bonds.*
FDA Label Image

Theophylline 02

Theophylline 02
Theophylline (Anhydrous) Extended-Release Tablets 400 mg label from Rhodes Pharmaceuticals LLC. The label indicates a package size of 100 tablets. The product is marketed by Rhodes Pharmaceuticals in Coventry, RI, and manufactured by Purdue Pharma in Canada. The label includes dosage storage instructions and a barcode with NDC 42858-701-01.*
FDA Label Image

Theophylline 03

Theophylline 03
Label for Theophylline (Anhydrous) Extended-Release Tablets 600 mg by Rhodes Pharmaceuticals LLC. The label indicates 100 tablets per bottle, Rx only, with storage instructions and pharmacist dispensing guidance. Manufactured by Purdue Pharma in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.